Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 6, 2024Cancer Immunology ImmunotherapyOpen Access

Unlocking the potential of HHLA2: identifying functional immune infiltrating cells in the tumor microenvironment and predicting clinical outcomes in laryngeal squamous cell carcinoma

View Full Paper
Ask AI
Bookmark
Share

Authors

WLWenjing LiJYJianqing YouHXHaixiang Xue

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Li et al. (2024) studied this question.

synapsesocial.com/papers/68e5d46db6db64358756a5e5https://doi.org/10.1007/s00262-024-03791-6
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Overexpression of HHLA2 in human clear cell renal cell carcinoma is significantly associated with poor survival of the patients2019 · 74 citations
  2. 2B7‐H5/ CD 28H is a co‐stimulatory pathway and correlates with improved prognosis in pancreatic ductal adenocarcinoma2018 · 33 citations
  3. 3HHLA2 is a novel prognostic predictor and potential therapeutic target in malignant glioma2019 · 28 citations
  4. 4KIR3DL3 Is an Inhibitory Receptor for HHLA2 that Mediates an Alternative Immunoinhibitory Pathway to PD12020 · 110 citations
  5. 5KIR3DL3-HHLA2 and TMIGD2-HHLA2 pathways: The dual role of HHLA2 in immune responses and its potential therapeutic approach for cancer immunotherapy2022 · 38 citations